An 18-year-old boy presents to the clinic with shortness of breath and fever for the last 2 days. He also has a cough for the same duration. He is asthmatic and uses inhaled albuterol for symptom relief when required. He used albuterol today 3 times at 10-minute intervals but has not had relief of his symptoms. On physical examination, his temperature is 38.3°C (101.0°F), pulse is 130/min, blood pressure is 116/80 mm Hg, and respirations are 28/min. Auscultation of the chest reveals bilateral crackles. Considering that he has already taken inhaled albuterol and has tachycardia, the physician nebulizes him with inhaled ipratropium bromide, which significantly improves his symptoms. Which of the following is the mechanism of action of this drug?

Inhibition of vagally-mediated contraction of bronchial smooth muscles

Inhibition of degranulation of mast cells

Inhibition of phosphodiesterase-4, leading to prevention of release of cytokines and chemokines

Inhibition of adenosine receptors in the respiratory tract

Stimulation of β2-adrenergic receptors in bronchial smooth muscle

A 26-year-old man is brought to the hospital by his wife who complains that her husband has been behaving oddly for the past few hours. The patient’s wife says that she has known him for only 4 months. The wife is unable to give any past medical history. The patient’s speech is difficult to follow, and he seems very distracted. After 15 minutes, he becomes agitated and starts to bang his head on a nearby pillar. He is admitted to the psychiatric ward and is given an emergency medication, after which he calms down. In the next 2 days, he continues to become agitated at times and required 2 more doses of the same drug. On the 4th day of admission, he appears very weak, confused, and does not respond to questions appropriately. His vital signs include: temperature 40.0°C (104.0°F), blood pressure 160/95 mm Hg, and pulse 114/min. On physical examination, he is profusely diaphoretic. He is unable to stand upright or even get up from his bed. Which of the following is the mechanism of action of the drug which most likely caused this patient’s current condition?

Agonistic effect on dopamine receptors

Muscarinic antagonists for USMLE Step 2 CK: High-Yield Pharmacology Lessons

Mechanism of Action - Acetylcholine's Off‑Switch

Competitive Antagonism: Muscarinic antagonists reversibly bind to muscarinic receptors (M1, M2, M3), preventing acetylcholine (ACh) from binding and activating them.
- This is a surmountable blockade; it can be overcome by increasing local ACh concentrations (e.g., with cholinesterase inhibitors).
Parasympatholytic Action: By blocking ACh, these drugs inhibit parasympathetic nerve stimulation, effectively turning off the "rest and digest" response.

⭐ Tissues with high intrinsic parasympathetic tone (e.g., SA node, gut, bladder) are most sensitive to blockade.

The Drugs - Atropine & Friends

Muscarinic antagonists are classified by their chemical structure, which dictates their ability to cross the blood-brain barrier (BBB).

Amine Type	Agents	CNS Access	Clinical Use
Tertiary	Atropine, Scopolamine, Benztropine	✅ Crosses BBB (Lipophilic)	Bradycardia, motion sickness, Parkinson's, extrapyramidal symptoms
Quaternary	Ipratropium, Tiotropium	❌ No CNS entry (Hydrophilic)	COPD, Asthma 📌 'I pray I can breathe'

Clinical Uses - The 'Dry & Fast' Toolkit

Cardiovascular: Atropine for symptomatic bradycardia (↑ heart rate).
Respiratory: Ipratropium and tiotropium for bronchodilation in COPD and asthma.
Genitourinary: Oxybutynin and tolterodine for overactive bladder.
CNS:
- Parkinsonism: Benztropine to alleviate tremor and rigidity.
- Motion Sickness: Scopolamine (transdermal patch).
Antidote: Atropine is critical for reversing muscarinic toxicity in organophosphate poisoning.

⭐ Glycopyrrolate is used preoperatively to reduce airway secretions; its quaternary structure prevents it from crossing the blood-brain barrier, thus avoiding CNS side effects.

Adverse Effects & Toxicity - The Atropine Fever

Widespread blockade of muscarinic receptors leads to a classic toxidrome, especially in the elderly.
Symptoms: Tachycardia, mydriasis (dilated pupils), cycloplegia (blurry vision), dry mouth (xerostomia), urinary retention, constipation, and delirium.
📌 Mnemonic: "Blind as a bat" (mydriasis), "Mad as a hatter" (delirium), "Red as a beet" (flushing), "Hot as a hare" (hyperthermia), "Dry as a bone" (anhidrosis).

Atropine Overdose Symptoms Mnemonic

⭐ Physostigmine, a tertiary amine acetylcholinesterase inhibitor, is the antidote because it crosses the blood-brain barrier to reverse both central and peripheral symptoms. Neostigmine cannot reverse CNS effects.

Contraindications - Patient Safety Alerts

Acute angle-closure glaucoma: Mydriasis can precipitate an acute attack.
Benign Prostatic Hyperplasia (BPH): Can cause acute urinary retention.
Bowel obstruction: May worsen or precipitate ileus.
Elderly: High risk of delirium, confusion, and cognitive impairment.

⭐ Systemic Effects from Topical Use: Ophthalmic preparations can be absorbed systemically, causing side effects, particularly in infants and the elderly.

High‑Yield Points - ⚡ Biggest Takeaways

Muscarinic antagonists are competitive inhibitors at muscarinic receptors.

Atropine is the prototype; it crosses the blood-brain barrier, causing CNS effects.

Classic atropine overdose signs: "Hot as a hare, dry as a bone, red as a beet, blind as a bat, mad as a hatter."

Key uses: bradycardia, COPD/asthma (ipratropium, tiotropium), and Parkinson's disease (benztropine).

Treats urge incontinence (oxybutynin) and used to induce mydriasis for eye exams.

Contraindicated in angle-closure glaucoma, BPH, and patients with delirium.

Continue reading on Oncourse

CONTINUE READING — FREE

or get the app

App Store|Google Play